Is this a gaffe - or an attempt by a senior executive of a major pharmaceutical company to steer the industry in a new direction? Is this the dawn and justification for 'tailored drugs'?
The Independent, London
Glaxo chief: Our drugs do not work on most patients
By Steve Connor, Science Editor
8 December 2003
A senior executive with Britain's biggest drugs company has admitted that most prescription medicines do not work on most people who take them.
Allen Roses, worldwide vice-president of genetics at GlaxoSmithKline (GSK), said fewer than half of the patients prescribed some of the most expensive drugs actually derived any benefit from them.
It is an open secret within the drugs industry that most of its products are ineffective in most patients but this is the first time that such a senior drugs boss has gone public. His comments come days after it emerged that the NHS drugs bill has soared by nearly 50 per cent in three years, rising by
Hydroxychloroquine hit job; PCR tests to detect covid infection scientifically unsound; Statins don’t reduce risk of dying from heart disease; Forbes says no more personal science research; Agrichemical farming failures; News in Brief